1. Scrip
  2. >>Focus On Asia
  3. >>China

Stay Or Exit? Global Health Players Ponder New China Trajectory

Localization Takes New Shape

 
• By Brian Yang

It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.

Charting a different path.
Global health players explore new China strategies amid mounting challenges • Source: Shutterstock

Top executives from AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Company, GSK plc, Pfizer Inc., Novartis AG, and Takeda Pharmaceutical Co. Ltd. have again gathered under one roof for the annual China Development Forum held March 24-25 in Beijing.

However, the challenges facing each CEO might be slightly different this year at the meeting, organized by the Chinese central government's China Development Research Foundation as an opportunity to interact with

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

More from Focus On Asia